(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
----------
AIM - WINNERS
----------
Oxford BioDynamics PLC, up 17% at 40.30p, 12-month range 9.20p-42.00p. The biotechnology company receives a reimbursement code for EpiSwitch prostate screening test, which boosts the predictive accuracy of current standard PSA test from 55%, to 94% for determining the presence or absence of prostate cancer. The code comes from the American Medical Association, with payors able to bill for the test using the code from January 1. Shares hit this 12-month high on Tuesday.
----------
Renalytix PLC, up 16% at 72.5 pence, 12-month range 44.00p-155.00p. The kidney health-focused diagnostics company says the US Centers for Medicare & Medicaid Services prices the kidneyintelX.dkd test at USD950 each. When finalised in the fourth quarter of 2023, this pricing will be effective as of January 1 and maintained for a minimum of three years. Renalytix says the CMS action "affirms the value of the KidneyIntelX testing platform and importantly streamlines the pathway for maintaining and expanding health insurance coverage in the US". The company also believes it provides a "strong pricing basis" for international distribution agreements.
----------
Aurrigo International PLC, up 14% at 167.50p, 12-month range 54.00p-174.00p. Aurrigo signs a formal partnership agreement with International Consolidated Airlines Group SA for the deployment and demonstration of Aurrigo's autonomous aviation solutions within the UK. Aurrigo says it expects the partnership to follow a similar phasing to its ongoing agreement with Changi Airport Group in Singapore. It expects the deal to lead to the deployment of a small fleet during the first half of 2025. The trial programme is valued at around GBP250,000. Coventry, England-based Aurrigo provides autonomous and semi-autonomous vehicle technology to the aviation, ground handling and cargo industries.
----------
AIM - LOSERS
----------
Safestyle UK PLC, down 45% at 2.40p, 12-month range 54.00-174.00p. The retailer and manufacturer of PVCu replacement windows and doors says it is working with shareholders and third party investors to secure a cash injection and is discussing ways to strengthen its balance sheet. As part of these discussions, Safestyle has engaged with "a number of third parties who have expressed interest in investing in the group." On Tuesday, Safestyle said the discussions have been "productive and remain ongoing."
----------
By Greg Rosenvinge, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Renalytix Plc (RENX)
Aurrigo Intl (AURR)
Oxford Biodyn (OBD)